Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

Genzyme Corporation

Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopedics, transplant, cancer, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial research and development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

Search Projects

  • Senior Vice President, Medical Affairs
  • Vice President and Allston Landing Site Manager
  • Group Vice President, Drug Discovery
  • Vice President, Orthopaedic Research
  • Vice President, Oncology Research
  • Senior Vice President, Global Clinical Operations
  • Senior Vice President, Global Product Quality
  • Medical Director – Cardiovascular
  • Vice President Quality – Site Leader
  • Senior Director Quality Assurance